GlassScriptPhysician profile
David William Conn
NPI 1164099958
$2,211.08
in general payments reported to CMS, 2019-2025
30 companies · $356 in 2025
The $356 reported for 2025 was more than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $139 · 2022: $412 · 2023: $817 · 2024: $487 · 2025: $356.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,660.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,659.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $444.36 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Shockwave Medical, INC | $269.39 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $186.99 | 2023-2025 | Jeti, Esprit |
| Boston Scientific Corporation | $154.28 | 2022-2024 | Varithena Administration Pack |
| Penumbra, INC. | $148.72 | 2025 | Indigo System |
| Cardiovascular Systems INC. | $118.63 | 2021-2022 | |
| Lemaitre Vascular, INC. | $107.78 | 2023-2025 | Restoreflow, Artegraft Vascular Graft, Xenosure Biologic Patch |
| Medtronic, INC. | $92.13 | 2022-2023 | Endurant Iis |
| Philips North America LLC | $67.72 | 2023 | |
| Terumo Medical Corporation | $66.49 | 2022-2023 | Azur Cx Detachable |
| W. L. Gore & Associates, INC. | $52.16 | 2023-2025 | Gore Viabahn Vbx Balloon Expandable Endo |
| Neuros Medical, INC. | $44.21 | 2025 | Altius |
| Aroa Biosurgery Incorporated | $43.47 | 2022-2024 | |
| Acera Surgical, INC. | $37.36 | 2024 | Restrata Wound Matrix |
| Artivion, INC. | $37.20 | 2023 | Jotec Products, Bioglue Surgical Adhesive, Vascular |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lsi Solutions INC | $33.86 | 2024 | Cor-Knot |
| Janssen Pharmaceuticals, INC | $33.32 | 2021-2022 | |
| Truvic Medical, INC. | $27.92 | 2022 | |
| Cvrx, INC. | $27.70 | 2024 | Barostim Neo System |
| Cardiva Medical, INC. | $25.84 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $25.66 | 2025 | |
| Angiodynamics, INC. | $23.19 | 2025 | Auryon Laser System 100-120 Vac |
| Integra Lifesciences Corporation | $22.79 | 2024 | Integra, Integra Dermal Regeneration Template, Primatrix |
| E.R. Squibb & Sons, L.L.C. | $20.68 | 2024 | Eliquis |
| Coloplast Corp | $18.69 | 2024 | |
| Bard Peripheral Vascular, INC. | $18.16 | 2021 | |
| Ethicon US, LLC | $17.03 | 2023 | Surgicel Nu-Knit |
| Hydrofera LLC | $16.00 | 2024 | Hydrofera Blue |
| Solventum Corporation | $15.19 | 2024 | V.A.C. Veraflo, Prevena |
| Molnlycke Health Care US, LLC | $14.16 | 2024 | Mepilex Border Post-Op Ag |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Conn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.